True hypoglycaemia secondary to treatment with granulocyte colony stimulating factor (G-CSF) in a diabetic patient with non-small cell lung cancer

Lung Cancer

Volumn 75, Issue 1, 2012, Pages 133-135

  Coward, Jermaine I G ^a   Nathavitharana, Ravindhi ^a   Popat, Sanjay ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Blood glucose; G CSF; Hypoglycaemia; Neutropenia; Non small cell lung cancer; Type II diabetes

Indexed keywords

CISPLATIN; GEMCITABINE; GLICLAZIDE; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; METFORMIN; SITAGLIPTIN;

ADULT; ARTICLE; CASE REPORT; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LEUKOCYTOSIS; LUNG NON SMALL CELL CANCER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; DIABETES MELLITUS, TYPE 2; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYPOGLYCEMIA; LEUKOCYTOSIS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 83555161694     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.11.001     Document Type: Article

References (10)

1. Illarramendi J.J., Iruin A., Mitxelena I. Artifactual hypoglycaemia during treatment with filgrastim (rHu-met-G-CSF). Eur J Cancer 1997, 33(9):1520.
2. Goodenow T.J., Malarkey W.B. Leukocytosis and artifactual hypoglycemia. JAMA 1977, 237(18):1961-1962.
3. Canivet B., Squara P., Elbaze P., Gratecos N., Cassuto J.P., Dujardin P., et al. In vitro glucose consumption in severe hyperleukocytosis. A cause of factitious hypoglycemia. Sem Hop 1983, 59(8):533-536.
4. Nourrisson C., Batisse M., Sapin V., Bouvier D. Pseudo-hypoglycemia and hyperleukocytosis: a case report. Ann Biol Clin (Paris) 2010, 68(4):490-494.
5. Gaudreau S., Guindi C., Menard M., Benabdallah A., Dupuis G., Amrani A. GM-CSF induces bone marrow precursors of NOD mice to skew into tolerogenic dendritic cells that protect against diabetes. Cell Immunol 2010, 265(1):31-36.
6. Gaudreau S., Guindi C., Menard M., Besin G., Dupuis G., Amrani A. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J Immunol 2007, 179(6):3638-3647.
7. Krakowski M., Abdelmalik R., Mocnik L., Krahl T., Sarvetnick N. Granulocyte macrophage-colony stimulating factor (GM-CSF) recruits immune cells to the pancreas and delays STZ-induced diabetes. J Pathol 2002, 196(1):103-112.
8. Uemura Y., Kobayashi M., Nakata H., Harada R., Kubota T., Taguchi H. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Int J Cancer 2004, 109(6):826-832.
9. Ding D.X., Rivas C.I., Heaney M.L., Raines M.A., Vera J.C., Golde D.W. The alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway. Proc Natl Acad Sci USA 1994, 91(7):2537-2541.
10. Spielholz C., Heaney M.L., Morrison M.E., Houghton A.N., Vera J.C., Golde D.W. Granulocyte-macrophage colony-stimulating factor signals for increased glucose uptake in human melanoma cells. Blood 1995, 85(4):973-980.